Free Trial

Ryan Specialty Holdings Inc. (NYSE:RYAN) Stake Increased by Los Angeles Capital Management LLC

Ryan Specialty logo with Finance background

Los Angeles Capital Management LLC lifted its stake in Ryan Specialty Holdings Inc. (NYSE:RYAN - Free Report) by 30.7% during the first quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 307,305 shares of the company's stock after acquiring an additional 72,263 shares during the quarter. Los Angeles Capital Management LLC owned approximately 0.12% of Ryan Specialty worth $22,701,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also modified their holdings of RYAN. Wealth Alliance LLC bought a new stake in shares of Ryan Specialty during the first quarter worth approximately $303,000. C WorldWide Group Holding A S raised its position in Ryan Specialty by 1.2% during the first quarter. C WorldWide Group Holding A S now owns 177,191 shares of the company's stock valued at $13,089,000 after purchasing an additional 2,055 shares in the last quarter. Whittier Trust Co. of Nevada Inc. raised its position in Ryan Specialty by 281.6% during the first quarter. Whittier Trust Co. of Nevada Inc. now owns 332 shares of the company's stock valued at $25,000 after purchasing an additional 245 shares in the last quarter. Sumitomo Life Insurance Co. acquired a new position in shares of Ryan Specialty during the first quarter worth $1,056,000. Finally, Louisiana State Employees Retirement System increased its holdings in shares of Ryan Specialty by 1.0% during the first quarter. Louisiana State Employees Retirement System now owns 29,800 shares of the company's stock worth $2,201,000 after buying an additional 300 shares in the last quarter. Institutional investors and hedge funds own 84.82% of the company's stock.

Insider Buying and Selling at Ryan Specialty

In related news, EVP Mark Stephen Katz sold 14,377 shares of the stock in a transaction on Friday, June 13th. The shares were sold at an average price of $65.84, for a total transaction of $946,581.68. Following the completion of the sale, the executive vice president owned 1,117 shares in the company, valued at $73,543.28. This represents a 92.79% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, Director David P. Bolger sold 5,000 shares of the company's stock in a transaction on Tuesday, June 3rd. The stock was sold at an average price of $70.80, for a total transaction of $354,000.00. Following the transaction, the director owned 71,467 shares of the company's stock, valued at approximately $5,059,863.60. The trade was a 6.54% decrease in their position. The disclosure for this sale can be found here. Corporate insiders own 52.21% of the company's stock.

Analyst Upgrades and Downgrades

A number of equities analysts have recently issued reports on RYAN shares. Barclays cut their price objective on shares of Ryan Specialty from $83.00 to $79.00 and set an "overweight" rating on the stock in a research report on Monday, July 7th. The Goldman Sachs Group raised shares of Ryan Specialty from a "neutral" rating to a "buy" rating and increased their target price for the company from $74.00 to $81.00 in a research report on Tuesday, May 13th. TD Cowen started coverage on shares of Ryan Specialty in a report on Thursday, April 10th. They issued a "buy" rating and a $89.00 price objective for the company. Morgan Stanley cut their price target on shares of Ryan Specialty from $80.00 to $78.00 and set an "overweight" rating for the company in a report on Monday, July 14th. Finally, Wells Fargo & Company decreased their target price on shares of Ryan Specialty from $65.00 to $63.00 and set an "equal weight" rating on the stock in a research report on Thursday, July 10th. One equities research analyst has rated the stock with a sell rating, three have given a hold rating and eight have given a buy rating to the stock. According to MarketBeat.com, Ryan Specialty has a consensus rating of "Moderate Buy" and a consensus target price of $74.83.

Read Our Latest Research Report on Ryan Specialty

Ryan Specialty Stock Performance

RYAN stock traded up $0.40 during midday trading on Tuesday, hitting $65.67. 1,070,117 shares of the stock traded hands, compared to its average volume of 927,132. The firm has a market cap of $17.23 billion, a P/E ratio of 193.14, a PEG ratio of 1.79 and a beta of 0.66. The company has a debt-to-equity ratio of 3.45, a current ratio of 1.05 and a quick ratio of 1.05. The stock's fifty day simple moving average is $67.72 and its 200-day simple moving average is $68.24. Ryan Specialty Holdings Inc. has a 1-year low of $56.59 and a 1-year high of $77.16.

Ryan Specialty (NYSE:RYAN - Get Free Report) last released its quarterly earnings results on Thursday, May 1st. The company reported $0.39 earnings per share (EPS) for the quarter, meeting analysts' consensus estimates of $0.39. The business had revenue of $690.17 million for the quarter, compared to the consensus estimate of $680.80 million. Ryan Specialty had a net margin of 6.97% and a return on equity of 47.70%. The business's revenue was up 25.0% on a year-over-year basis. During the same period in the previous year, the firm earned $0.35 EPS. On average, analysts expect that Ryan Specialty Holdings Inc. will post 2.29 earnings per share for the current year.

Ryan Specialty Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Tuesday, May 27th. Shareholders of record on Tuesday, May 13th were issued a dividend of $0.12 per share. This represents a $0.48 annualized dividend and a yield of 0.73%. The ex-dividend date of this dividend was Tuesday, May 13th. Ryan Specialty's dividend payout ratio (DPR) is presently 141.18%.

Ryan Specialty Profile

(Free Report)

Ryan Specialty Holdings, Inc operates as a service provider of specialty products and solutions for insurance brokers, agents, and carriers in the United States, Canada, the United Kingdom, Europe, and Singapore. It offers distribution, underwriting, product development, administration, and risk management services by acting as a wholesale broker and a managing underwriter.

Read More

Institutional Ownership by Quarter for Ryan Specialty (NYSE:RYAN)

Should You Invest $1,000 in Ryan Specialty Right Now?

Before you consider Ryan Specialty, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Ryan Specialty wasn't on the list.

While Ryan Specialty currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

A Beginner's Guide to Investing in Cannabis Cover

Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

AI Stocks Are Printing Money — These 3 Are Just Getting Started
Why Drone Stocks Are Skyrocketing Right Now!
Pelosi Makes Big Bet on Broadcom—Here’s Why It Matters

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines